Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.
GLP-1RAs and opioid use disorder: a new frontier in addiction treatment
Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
A Rip Van Winkle Portfolio: Invest In These Companies And Forget You Did It
Long-term investments in top tech, health, and consumer staples for stability, growth, and reliable returns. Read what ...
Medscape1h
Despite Price Caps, Some Still Struggle to Access Insulin
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Factbox-Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli ...
Next generation weight loss drugs aim to save muscle
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
The next battle in the weight-loss drug war is focussed on muscle growth
Doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures ...
Why we need to rethink the discourse on body positivity in the age of Ozempic
As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...
‘We made 434pc on one stock – now we’re hunting for the next Ozempic’
Fund Of The Week quizzes fund managers about how they’re investing your money. If you’d like to suggest which funds you want ...
Ibj.com10h
Lebanon planning board OKs design for Lilly Medicine Foundry at LEAP District
Lebanon Plan Commission on Monday night unanimously approved a design plan for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...
The American Journal of Managed Care14h
Ixekizumab Induction Boosts Psoriasis Response, May Lower Drug Survival
A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...
Eli Lilly & Co. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...